AGP Picks
View all

European News Update: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on European News Update.

Press releases published on October 24, 2026

OEM Lithium Battery Manufacturer With ISO 9001, UL, CB and UN38.3 Certification — Howell Energy's Quality Promise
Sustainable Merino Wool Base Layer for Outdoor and Travel Use from WOOLCANO with RWS Certification
How to Select Skin-Friendly Merino Wool Base Layer for Sensitive Skin: Insights from WOOLCANO
100% Pure Merino Wool Base Layer Online Store: WOOLCANO's Approach to Authenticity and Quality Control
Custom Lithium Ion Battery Pack: Howell Energy's UL and IEC 62133 Certified OEM/ODM Services
LiFePO4 Golf Cart Battery: Howell Energy's Drop-In Replacement Solutions for 36V and 48V Golf Carts
Solar Batteries for Home Energy Storage: Howell Energy's Rechargeable LiFePO4 Power Wall Solutions
Emergency Lighting Battery: Howell Energy's NiMH and LiFePO4 Backup Power Solutions for Safety Systems
LiFePO4 Battery for Solar and RV: Howell Energy's 12V-74V Deep Cycle Solutions With UL and CE Certification
LiFePO4 Battery vs Lead-Acid: Which Is Better for Solar, RV and Golf Cart Applications
Lithium Ion Battery Manufacturer: Howell Energy's 20+ Years of Custom Battery Pack Solutions
Award-Winning Children's Author Debora Menieur Nunez Launches Website and Indie Bookstore Directory for SEL Book
Flagstaff Celebrates 25th Anniversary as the World's First International Dark Sky City
KFSH Extends Emergency Access Through Virtual Care and Specialist Coordination
UK Financial Ltd Launches MAYA CHAIN and Begins Digital Asset Migration
Quanta Presents Positive Clinical Combination Data in KRAS G12D-Mutant CRC at ESMO and Highlights Pan-KRAS Progress
Parabilis Medicines Presents Updated Phase 1/2 Data for Zolucatetide Demonstrating Compelling Efficacy and Favorable Safety and Tolerability Profile in Patients with Desmoid Tumors
NANOBIOTIX Announces Final Data from Phase 1 Study Evaluating JNJ-1900 (NBTXR3) With Immune Checkpoint Inhibitors as a 2L+ Therapy in Anti-PD-1-Resistant Primary Cutaneous Melanoma
NANOBIOTIX annonce les résultats complets de l’étude de Phase 1 évaluant JNJ-1900 (NBTXR3) en combinaison avec des inhibiteurs de points de contrôle immunitaires chez des patients atteints de mélanome cutané résistant aux anti-PD-1, en traitement de de…
Tecnover Celebrates 41 Years of Italian Airless Spray-Painting Innovation

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

European News Update

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.